ShareValue scores for 600422.SHG: Valuation 62, Quality 23, Growth 9, Health 22.

600422.SHG
SSE

KPC Pharmaceuticals Inc

CN¥8.82(+0.80%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

1% to 16%
Valuation
62
Fair Value
Price vs Value
Quality
23
Weak
Business Strength
Growth
9
Weak
Revenue & Earnings
Health
22
Stressed
Financial Stability
Momentum
29
Bearish
Price Trend

Company Details

About

KPC Pharmaceuticals,Inc., a pharmaceutical company, engages in the research and development, production, marketing, and commercial wholesale of botanical drugs and natural drugs in the People's Republic of China and internationally. It offers artemisia annua series, panax notoginseng, gastrodia, artemether, comether tablets, specialty herbal products, classic prescription for bones and joint, antibiotics, immunosuppressive, oral products, injections, and other products, as well as engages in the wholesale and retail of medicines and equipment. The company offers products in the field of cardiovascular and cerebrovascular, orthopedics series, antimalarial, gynecology, digestive system, and others treatments. It offers its products under Luotai, Tianxuanqing, Artemedine, Artem, and Arco brands. The company was formerly known as Kunming Pharmaceutical Corporation and changed its name to KPC Pharmaceuticals, Inc. in April 2015. KPC Pharmaceuticals,Inc. was founded in 1951 and is based in Kunming, the People's Republic of China.

Score Analysis

AI Investment Thesis

Data as of:Aug 7, 2026
|
Last calculated:Aug 7, 2026